Furthermore, it was discovered that the anti-helminthic agent clonidine could stimulate miR-148a expression, consequently suppressing PXR expression and diminishing the population of CSCs while also enhancing the efficacy of chemotherapeutic agents to mitigate CSC chemoresistance and tumor recurrence [26]. The gene discussed is NR1I2; the disease is neoplasm.